Gide has advised Sofinnova Partners on the structuring of a parallel fund to the Sofinnova Capital XI strategy, dedicated to early-stage biotech and medtech, which has raised €650 million.
The Gide team was composed of Guillaume Goffin, partner, and Hugo Panahpoursalehi, associate.